AGV欧版和亚洲版尺寸差别,亚洲视频在线观看,亚洲男人天堂,亚洲视频一区,亚洲中文字幕在线观看,亚洲国产成人精品女人久久久

CN
Strategic layout
  • Development strategy
  • Product strategy
  • Technology strategy
  • Talent strategy
  • International strategy
  • Advance into the United States, realize the dual reporting of core products in China and the United States,
    and firmly practice the "Microdiag of the world

    Project name Core technologies
    AD early screening Neuro-derived exosome blood test, completed research and development, ready to apply for US breakthrough medical device certification
    Covid-19 nucleic acid self-test NuRapid new technology, similar to US Cue Health, declares US EUA as a US company
    Pneumonia in children
    Streptococcus
    Develop home or community testing with NuRapid technology for nucleic acid rapid testing, and plan to apply for US breakthrough medical device certification
    New products of exosomes Exosomal prostate cancer (blood test, urine test) The product series of tissue-specific exosomes will gradually apply for registration certificates in China, the United States and the European Union.
    Exosomal bowel cancer
    Exosomal liver cancer
    Exosomal breast cancer
    Exosome lung cancer
    Swipe to see full table

    Go abroad, enter the United States,
    It is the dream and expectation that the Microdiag people have been sticking to for 12 years;

    In 5 years, Microdiag entered the first-tier market in the United States and obtained original international recognition and interest premium.

    Hotline: 0512-8187-9848

    Address: Building 16, Northwest District, Suzhou Nano City, No. 99, Jinji Lake Avenue, Suzhou Industrial Park, Jiangsu Province

    欢迎光临: 博白县| 开原市| 随州市| 施秉县| 黄陵县| 中超| 洪洞县| 和静县| 娄烦县| 周至县| 上高县| 手游| 左贡县| 平乡县| 安宁市| 大连市| 从化市| 綦江县| 漳平市| 沂源县| 黑水县| 光山县| 南靖县| 镇康县| 巴彦县| 汶上县| 珠海市| 无极县| 称多县| 洪湖市| 藁城市| 漳州市| 湘潭县| 务川| 博罗县| 九龙城区| 衡南县| 德江县| 六安市| 德阳市| 宁陵县|